Saol Therapeutics

Monoclonal antibodies in development to prevent respiratory syncytial virus (RSV) in children will not only have to satisfy US Food and Drug Administration requirements for product licensure, they wil

Medtronic PLC hopes the publication of the results from a major randomized trial of its SynchroMed II implanted intrathecal baclofen (ITB) infusion system will draw attention to this therapy for po

IN VITRO DIAGNOSTICS Alliances Angle PLC Qiagen NV Angle PLC and Qiagen NV will co-promote each other’s liquid biopsy solutions for cancer detection. (Sep.) To the deal Angle contributes its

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal in